Adeno-Associated Virus VP1u Exhibits Protease Activity

Adeno-associated viruses (AAVs) are being developed for gene delivery applications, with more than 100 ongoing clinical trials aimed at the treatment of monogenic diseases. In this study, the unique N-terminus of AAV capsid viral protein 1 (VP1u), containing a canonical group XIII PLA<sub>2<...

Full description

Bibliographic Details
Main Authors: Justin J. Kurian, Renuk Lakshmanan, William M. Chmely, Joshua A. Hull, Jennifer C. Yu, Antonette Bennett, Robert McKenna, Mavis Agbandje-McKenna
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Viruses
Subjects:
AAV
Online Access:https://www.mdpi.com/1999-4915/11/5/399
id doaj-b6837595f4834aa7978d20ab215076b9
record_format Article
spelling doaj-b6837595f4834aa7978d20ab215076b92020-11-25T02:01:07ZengMDPI AGViruses1999-49152019-04-0111539910.3390/v11050399v11050399Adeno-Associated Virus VP1u Exhibits Protease ActivityJustin J. Kurian0Renuk Lakshmanan1William M. Chmely2Joshua A. Hull3Jennifer C. Yu4Antonette Bennett5Robert McKenna6Mavis Agbandje-McKenna7Department of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USADepartment of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USADepartment of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USADepartment of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USADepartment of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USADepartment of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USADepartment of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USADepartment of Biochemistry and Molecular Biology, Center for Structural Biology, The McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USAAdeno-associated viruses (AAVs) are being developed for gene delivery applications, with more than 100 ongoing clinical trials aimed at the treatment of monogenic diseases. In this study, the unique N-terminus of AAV capsid viral protein 1 (VP1u), containing a canonical group XIII PLA<sub>2</sub> enzyme domain, was observed to also exhibit proteolytic activity. This protease activity can target casein and gelatin, two standard substrates used for testing protease function but does not self-cleave in the context of the capsid or target globular proteins, for example, bovine serum albumin (BSA). However, heated BSA is susceptible to VP1u-mediated cleavage, suggesting that disordered proteins are substrates for this protease function. The protease activity is partially inhibited by divalent cation chelators ethylenediaminetetraacetic acid (EDTA) and ethylene-bis(oxyethylenenitrilo)tetraacetic acid (EGTA), and human alpha-2-macroglobulin (A2M), a non-specific protease inhibitor. Interestingly, both the bovine pancreatic (group VIIA) and bee venom (group III) PLA<sub>2</sub> enzymes also exhibit protease function against casein. This indicates that PLA<sub>2</sub> groups, including VP1u, have a protease function. Amino acid substitution of the PLA<sub>2</sub> catalytic motif (<sup>76</sup>HD/AN) in the AAV2 VP1u resulted in attenuation of protease activity, suggesting that the protease and PLA<sub>2</sub> active sites are related. However, the amino acid substitution of histidine H38, which is not involved in PLA<sub>2</sub> function, to alanine, also affects protease activity, suggesting that the active site/mechanism of the PLA<sub>2</sub> and protease function are not identical.https://www.mdpi.com/1999-4915/11/5/399Adeno-associated virusAAVproteasephospholipase-A<sub>2</sub>PLA<sub>2</sub>
collection DOAJ
language English
format Article
sources DOAJ
author Justin J. Kurian
Renuk Lakshmanan
William M. Chmely
Joshua A. Hull
Jennifer C. Yu
Antonette Bennett
Robert McKenna
Mavis Agbandje-McKenna
spellingShingle Justin J. Kurian
Renuk Lakshmanan
William M. Chmely
Joshua A. Hull
Jennifer C. Yu
Antonette Bennett
Robert McKenna
Mavis Agbandje-McKenna
Adeno-Associated Virus VP1u Exhibits Protease Activity
Viruses
Adeno-associated virus
AAV
protease
phospholipase-A<sub>2</sub>
PLA<sub>2</sub>
author_facet Justin J. Kurian
Renuk Lakshmanan
William M. Chmely
Joshua A. Hull
Jennifer C. Yu
Antonette Bennett
Robert McKenna
Mavis Agbandje-McKenna
author_sort Justin J. Kurian
title Adeno-Associated Virus VP1u Exhibits Protease Activity
title_short Adeno-Associated Virus VP1u Exhibits Protease Activity
title_full Adeno-Associated Virus VP1u Exhibits Protease Activity
title_fullStr Adeno-Associated Virus VP1u Exhibits Protease Activity
title_full_unstemmed Adeno-Associated Virus VP1u Exhibits Protease Activity
title_sort adeno-associated virus vp1u exhibits protease activity
publisher MDPI AG
series Viruses
issn 1999-4915
publishDate 2019-04-01
description Adeno-associated viruses (AAVs) are being developed for gene delivery applications, with more than 100 ongoing clinical trials aimed at the treatment of monogenic diseases. In this study, the unique N-terminus of AAV capsid viral protein 1 (VP1u), containing a canonical group XIII PLA<sub>2</sub> enzyme domain, was observed to also exhibit proteolytic activity. This protease activity can target casein and gelatin, two standard substrates used for testing protease function but does not self-cleave in the context of the capsid or target globular proteins, for example, bovine serum albumin (BSA). However, heated BSA is susceptible to VP1u-mediated cleavage, suggesting that disordered proteins are substrates for this protease function. The protease activity is partially inhibited by divalent cation chelators ethylenediaminetetraacetic acid (EDTA) and ethylene-bis(oxyethylenenitrilo)tetraacetic acid (EGTA), and human alpha-2-macroglobulin (A2M), a non-specific protease inhibitor. Interestingly, both the bovine pancreatic (group VIIA) and bee venom (group III) PLA<sub>2</sub> enzymes also exhibit protease function against casein. This indicates that PLA<sub>2</sub> groups, including VP1u, have a protease function. Amino acid substitution of the PLA<sub>2</sub> catalytic motif (<sup>76</sup>HD/AN) in the AAV2 VP1u resulted in attenuation of protease activity, suggesting that the protease and PLA<sub>2</sub> active sites are related. However, the amino acid substitution of histidine H38, which is not involved in PLA<sub>2</sub> function, to alanine, also affects protease activity, suggesting that the active site/mechanism of the PLA<sub>2</sub> and protease function are not identical.
topic Adeno-associated virus
AAV
protease
phospholipase-A<sub>2</sub>
PLA<sub>2</sub>
url https://www.mdpi.com/1999-4915/11/5/399
work_keys_str_mv AT justinjkurian adenoassociatedvirusvp1uexhibitsproteaseactivity
AT renuklakshmanan adenoassociatedvirusvp1uexhibitsproteaseactivity
AT williammchmely adenoassociatedvirusvp1uexhibitsproteaseactivity
AT joshuaahull adenoassociatedvirusvp1uexhibitsproteaseactivity
AT jennifercyu adenoassociatedvirusvp1uexhibitsproteaseactivity
AT antonettebennett adenoassociatedvirusvp1uexhibitsproteaseactivity
AT robertmckenna adenoassociatedvirusvp1uexhibitsproteaseactivity
AT mavisagbandjemckenna adenoassociatedvirusvp1uexhibitsproteaseactivity
_version_ 1724958619260157952